LactaLogics is excited to announce the completion of our third processing run of breastmilk.
Completed at the TetraPak Pilot Plant located in Denton, Texas we successfully scaled our human milk processing, validating our technology while continuing to improve the quality of our milk.
Glenn Snow
“From day one, our goal is to get more babies on an exclusive human milk diet,” shared Glenn Snow, CEO and Co-Founder of LactaLogics. “An exclusive human milk diet can shorten a preterm infant’s hospital stay while reducing their risk of NEC, morbidity, mortality, and sepsis. We must do our due diligence to ensure that our technology and donor care processes and procedures are continuously improved upon, which is exactly what this pilot run allowed us to do.”
In our first run, we validated Gentle-UHT as able to offer superior retention of proteins, immune factors, and HMOs while protecting the milk against dangerous bacteria, viruses, molds, and spores. We created flexible calorie and protein amounts in our second run, allowing us to move forward with our in-hospital and outpatient pilot programs.
We maintained our momentum with this third run, further pushing our methodologies in collecting breast milk from donors in a way that is safe and supported, as well as how we processed the milk.
The completion of this third pilot run marks the end of a multi-year initiative. We started small with our R&D runs, iteratively scaling up and improving at each step. From donor screening, donor qualification, to milk pooling, testing, freezing, and thawing, we’ve now validated the commercialization of our processes.
“Gentle-UHT is going to allow us to become a reliable, high-volume supplier of 100% human milk and human milk fortifier. With over 50 runs behind us, we can move forward with commercialization in confidence,” continued Snow. “Up next is working through the final engineering needs of our automated, high-efficiency manufacturing processing system that is changing the future of neonatal nutrition.”
